Cervical cancer brachytherapy amid the pandemic: A single institutional case series

Abstract

Author(s): Zahra Siavashpour, Fatemeh Jafari*, Mahdi Aghili, Anya Jafari and Ramin Jaberi

Dose escalation to target volume during High Dose Rate brachytherapy was effectively employed to treat locally advanced cervical cancer patients who experienced prolongation of Overall Treatment Time (OTT) due to the COVID-19 pandemic. It was tried to achieve acceptable oncological outcomes while respecting the dose constraints of Organs at Risk (OARs).

Key Clinical Message: It was a severe challenge to obey the optimum treatment schedule of LACC cases during the coronavirus crisis. Increased risk of recurrence and mortality due to increased overall treatment time in cervical cancer patients proposes prioritizing.

Share this article

Awards Nomination
qr

Editors List

  • Prof. Elhadi Miskeen

    Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh

     

     

     

  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis

     

  • Fava Maria Giovanna

     

Google Scholar citation report
Citations : 208

Onkologia i Radioterapia received 208 citations as per Google Scholar report

Flyer image
Onkologia i Radioterapia peer review process verified at publons
Flyer image
Indexed In
  • Directory of Open Access Journals
  • Scimago
  • SCOPUS
  • EBSCO A-Z
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20
View More